| PROTARA THERAPEUT.DL-,001 |
| USA |
| Gesundheit |
| US74365U1079 / A2P4JE |
| 1KPA (Frankfurt) / TARA (NASDAQ) |
| FRA:1KPA, ETR:1KPA, 1KPA:GR, NASDAQ:TARA |
| - |
| https://protaratx.com/ |
|
Protara Therapeutics Inc. is a biotechnology company focused on developing transformative therapies for rare and speciality diseases. The company's primary function is to innovate treatment solutions for conditions with significant unmet medical need..
>Volltext.. |
| 200.34 Mio. EUR |
| 85.84 Mio. EUR |
| - |
| -60.29 Mio. EUR |
| -54.77 Mio. EUR |
| -1.17 EUR |
| 2.64 Mio. EUR |
| 12.75 Mio. EUR |
| -54.5 Mio. EUR |
| 15.22 |
| - |
| -30.53% |
| - |
| - |
| - |
| - |
| PROTARA |
| 11.08.26 |
|
||||
|
||||
|
||||
|